The Dose Effect of Mangrove Leaf Extract (Rhizophora apiculata) on Anticancer Activity in HeLa Cells
Downloads
Disease cancer caused by abnormal growth of tissue where there has been an error, fast and out of control. Judging from the fact of gender, more than 270,000 women die every year caused by cervical cancer. To inhibit the growth of cancer cells, a compound is needed that causes the cell cycle to stop so that the ability of cell proliferation decreases. Alkaloid compounds can inhibit proliferation through oxidative inhibition processes that can cause cancer. Mangrove plants have potential as anticancer, antimicrobial, and antioxidant. The content of chemical compounds found in mangroves are flavonoids, steroids, alkaloids, phenolites, saponins and tannins. These compounds show high antioxidant activity and are shown to have a real relationship with the properties of the material's bioactivity against cancer cells. One of the mangrove species is Rhizophora apiculata. The purpose of this study was to determine the IC50 value produced by Rhizophora apiculata mangrove leaf extract on HeLa cell viability and to see the effect of Rhizophora apiculata mangrove leaf extract dosage on HeLa cell viability. The method used in this research is the experimental method. The research parameters included yield, proximate test, phytochemical test, toxicity test, total phenol test, cytotoxicity test and LC-MS test. The experimental design used was a simple and complex completely randomized design (CRD) with the Tukey test.The results of this study showed that the highest yield was in the ethanol extract of 5.91%, while the n-hexane and ethyl acetate extracts respectively had yields of 1.18% and 1.31%. The results of the proximate test on the water content of leaves and powder were 64.53% and 13.86%, respectively, the results of the ash content in the leaves and powder of Rhizophora apiculata were 3.94% and 8.41%, respectively. while the water content in the extract obtained the highest yield in the ethanol extract of 21.42%, while the n-hexane extract and ethyl acetate extract were 11.08% and 15.42%, respectively. For phytochemical results, it was found that n-hexane extract only contained alkaloids, flavonoids and steroids. Ethyl acetate extract contains steroid compounds. Meanwhile, the ethanol extract contains the most bioactive compounds, namely saponins, flavonoids, tannins and triterpenoids. The toxicity test using the Brine Shrimp Lethality Test (BSLT) method resulted in the lowest IC50 of ethanol extract at 49.45 ppm while the n-hexane and ethyl acetate extracts were 251.63 ppm and 920.45 ppm respectively. In the total phenol test, the n-hexane extract was 66.79 mg GAE / 100 gr, 222.97 mg GAE / 100 gr ethyl acetate extract and 929.04 mg GAE / 100 gr ethanol extract. HeLa cell cytotoxicity testing using the MTT method (3- (4,5-dimethiltiazol-2-yl) -2,5-dipheniltetra zolium bromide) assay resulted in the highest cell viability value at a dose of 125 ppm of 46.97%. As for the doses of 250 ppm, 500 ppm 1000 ppm, and 2000 ppm resulted in a percentage of viability of 42.95% 37.70% 35.82% and 32.12%, respectively. The IC50 value of Rhizophora apiculata leaf extract was 64.42 ppm. This value indicates that the Rhizophora apiculata extract is toxic to HeLa cells.
Arifanti, L., Sukardiman, H. Studiawan, Rakhmawati dan L. Megawati. 2014. Uji aktivitas ekstrak biji ekstrak sirsak (Annona muricata L.) terhadap sel kanker mamalla secara In Vitro. Jurnal Farmasi dan Ilmu Kefarmasian Indonesia. 1(2): 63-66.
Ayuningtias, D. D. R., D. Nurahmanto dan V. A. Rosyidi. 2017. Optimasi komposisi polietilen dan lisetin sebagai kombinasi surfaktan pada sediaan nanoemulsi kafein. e-Jurnal Pustaka Kesehatan. 5(1): 157-163.
Damayanti, A dan E. A. Fitriana. 2012. Pemungutan Minyak Atsiri Mawar (Rose oil) Dengan Metode Maserasi. Jurnal Bahan Alam Terbarukan. 1(2): 1-8.
Faoziyah, A. R dan W. Kurniawan. 2017. Pemanfaatan ekstrak daun mangrove (Rhizophora mucronata sp.) dengan variasi pelarut sebagai bahan aktif sediaan farmasi terapi anti kanker. Journal of Health. 4(2): 68-74.
Haryoto dan S. P. Putri. 2019. Aktivitas sitotoksik ekstrak etanol, fraksi heksan, etil asetat, dan etanol-air dari daun mangrove Tancang (Bruguiera gymnorrhiza) terhadap sel kanker payudara T47D. URECOL. 177-183.
Irianty., A. F. Sitanggang dan R. D. A. Pohan. 2015. Pembuatan asam oksalat dari alang-alang (Imperata Cylindrica) dengan metode peleburan alkali. Jurnal Teknik Kimia USU. 4(1): 16-19.
Ismaryani, A., Salni., A. Setiawan dan Triwani. 2018. Aktivitas sitotoksik, antiproliferasi dan penginduksi apoptoksis daun salung (Psychotria viridiflora Reinw. Ex. Blume) terhadap sel kanker serviks HeLa. Jurnal Ilmu Kefarmasian Indonesia. 16(2): 206-213.
Ito, H., E. Kobayashi., S. Li., T. Hatono., D. Sugita., N. Kubo., S. Shimura., Y. Itoh and T. Yoshida. 2001. Megastigmane glycosides and an acylated triterpenoid from eriobotrya japonica. Journal of Natural Product. 64(6): 737-740.
Jacoeb, A. M., S. Purwaningsih dan Rinto. 2011. Anatomi, komponen bioaktif dan aktivitas antioksidan daun mangrove api- api (Avicennia marina). Jurnal Pengolahan Hasil Perikanan Indonesia. 14(2): 143-152.
Juanda, D dan H. Kesuma. 2015. Pemeriksaan metode IV A (inspeksi visual asam asetat) untuk pencegahan kanker serviks. Jurnal Kedokteran dan Kesehatan. 2(2): 169-174.
Kumalasari, M. L. F dan F. Andiarna. 2020. Uji fitokimia ekstrak etanol daun kemangi (Ocimum basilicum L). Indonesian Journal for Health Sciences. 4(1): 39-44.
Mahleda, M. dan N. Hartini. 2012. Post- traumatic growth pada pasien kanker payudara pasca mestektomi usia dewasa madya. Jurnal psikologi Klinis dan Kesehatan Mental. 1(2): 67-71.
Malongane, F., L. J. Mcgaw., H. Nyoni and F. N. Mudau. 2018. Metabolic profiling of four south African herbal teas using high resolution liquid chromatography-mass spectrometry and nuclear magnetic resonance. Food Chemistry. 257: 90-100.
Martono, B dan L. Udarno. 2015. Kandungan kafein dan karakteristik morfologi pucuk enam genotype the. J.TIDP. 2(2): 69-76.
Mukhlis, D. K., Rozirwan dan M. Hendri. 2018. Isolasi dan aktivitas antibakteri jamur endofit pada mangrove Rhizophora apiculata dari kawasan mangrove Tanjung Api-api Kabupaten Banyuasin Sumatera Selatan. Maspari Journal. 10(2): 151-160.
Mulia, K., A. E. Z. Hasan dan Suryani. 2016.Tptal Phenolic, anticancer and antioxidant activity of ethanol extract of Piper retrofractum Vahl from Pamekasan and Karang Asem. Current Biochemistry. 3(2): 80-90.
Ningrum, D. W., D. Kusrini dan E. Fachriyah. 2017. Uji aktivitas senyawa antioksidan senyawa flavonoid dari ekstrak etanol daun johar (Senna siamea Lamk). Jurnal kimia sains dan aplikasi. 20(3): 123-129.
Noviza, D., E. Zaini dan D. A. Juwita. 2014. Uji anti inflamasi campuran interaksi padat ibuprofen dan kafein. Prosiding Seminar dan Workshop. 207-211.
Prabowo, Y., H. Irawan dan A. Pratomo. 2014. Ekstraksi senyawa metabolit sekunder yang terdapat pada daun mangrove Xylocarpus granatum dengan pelarut yang berbeda. Marine Biology. 1-13.
Puspitasari, E., Rozirwan dan M. Hendri. 2018. Uji toksisitas dengan menggunakan metode Brine Shrimp Lethality Test (Bslt) pada ektrak mangrove (Avicennia marina, Rhizophora mucronata, Sonnetaria alba dan Xylocarpus granatum) yang berasal dari Banyuasin, Sumatera Selatan. Jurnal Biologi Tropis. 18(1):91-103.
Rachmadi, O., P. Ardiningsih dan A. Widiyantoro. 2018. Senyawa sitotoksik dari fraksi etil asetat daun daruju (Achantus ilicifolius Linn.) terhadap sel HeLa. Jurnal Kimia Khatulistiwa. 7(2) : 96-101.
Rahayu, M dan Roosmarinto. 2017. Kajian aktivitas antikanker ekstrak daun gude (cajanus cajan) terhadap sel kanker kolon secara in Vitro. Jurnal Teknologi Laboratorium. 6(1): 31-38.
Ridlo, A., R. Pramesti, Koesoemadji, E. Supriyantini dan N. Soenardjo. 2017. Aktivitas antioksidan ekstrak daun mangrove Rhizopora mucronata. Buletin Oseanografi Marina. 6(2):110-116.
Rio, S dan E. S. T. Suci. 2017. Presepsi tentang kanker serviks dan upaya prevensinya pada perempuan yang memiliki keluarga dengan riwayat kanker. Jurnal Kesehatan Reproduksi. 4(3): 159-169.
Santoso, V. P., J. Posangi., H. Awaloei dan R. Bara. 2015. Uji efek antibakteri daun mangrove Rhizophora apiculata terhadap bakteri Pseudemonas aeruginosa dan staphylococcus aureus. Jurnal e-Biomedik. 3(1): 399-405.
Sjafaraenan., E. Johannes dan S. N. Wulandari. 2019. Pengaruh interval dosis 2,44-19,53 µg/mL ekstrak n-heksana dari hydroid Aglaopheniacupressina lamoureoux terhadap aktivitas pertumbuhan sel HeLa. Jurnal Biologi Makassar. 4(1) : 11-19.
Sukmarianti, N. W. S., N. M. Suaniti dan I. M. D. Swantara. 2013. Identifikasi dan uji aktivitas antikanker ekstrak spons Ianthella baasta terhadap larva Artemia salina. Indonesian E-journal of Applied chemistry. 1(1): 14-19.
Suryati., E. Husni., W. Astuti dan N. Ranura. 2018. Karakterisasi dan sitotoksik daun jeruju (Acanthus illicifolius). Jurnal Sains Farmasi dan Klinis. 5(3): 207-211.
Tan, L. T., K. Chan., P. Pusparajah., W. Yin., T. M. Khan., L. Lee and B. Goh. 2019. Mangrove derived Streptomyces sp. MUM265 as a potential source of antioxidant and anticolon-cancer agents. BMC Microbiology. 19(38): 1-16.
Thao, N. P., B. T. T. Luyen., C. N. Diep., B. H. Tai., E. J. Kim., H. K. Kang., S. H. Lee., H. D. Jang., N. T. Cuong., N. V. Thanh., N. X. Cuong., N. H. Nam., C. V. Minh and Y. H. Kim. 2015. In vitro evaluation of the antioxidant and cytotoxic activities of constituents of the mangrove Lumnitzera racemosa willd. Archives of Pharmacal Research. 38: 446-455.
Usman. 2017. Uji Fitokimia dan Uji antibakteri dari akar mangrove Rhizophora apiculata terhadap bakteri Escherichia coli dan Staphylococcus aureus. Jurnal Kimia dan Pendidikan Kimia. 2(3): 169- 177.
Zhang and Chen. 2018. Current status and future directions of cancer immunotherapy. Journal of Cancer. 9(10): 1773-1781.
Copyright (c) 2021 Journal of Stem Cell Research and Tissue Engineering
This work is licensed under a Creative Commons Attribution 4.0 International License.
1. As an author you (or your employer or institution) may do the following:
- make copies (print or electronic) of the article for your own personal use, including for your own classroom teaching use;
- make copies and distribute such copies (including through e-mail) of the article to research colleagues, for the personal use by such colleagues (but not commercially or systematically, e.g. via an e-mail list or list server);
- present the article at a meeting or conference and to distribute copies of the article to the delegates attending such meeting;
- for your employer, if the article is a ‘work for hire', made within the scope of your employment, your employer may use all or part of the information in the article for other intra-company use (e.g. training);
- retain patent and trademark rights and rights to any process, procedure, or article of manufacture described in the article;
- include the article in full or in part in a thesis or dissertation (provided that this is not to be published commercially);
- use the article or any part thereof in a printed compilation of your works, such as collected writings or lecture notes (subsequent to publication of the article in the journal); and prepare other derivative works, to extend the article into book-length form, or to otherwise re-use portions or excerpts in other works, with full acknowledgement of its original publication in the journal;
- may reproduce or authorize others to reproduce the article, material extracted from the article, or derivative works for the author's personal use or for company use, provided that the source and the copyright notice are indicated, the copies are not used in any way that implies JSCRTE endorsement of a product or service of any employer, and the copies themselves are not offered for sale.
All copies, print or electronic, or other use of the paper or article must include the appropriate bibliographic citation for the article's publication in the journal.
2. Requests from third parties
Although authors are permitted to re-use all or portions of the article in other works, this does not include granting third-party requests for reprinting, republishing, or other types of re-use. Requests for all uses not included above, including the authorization of third parties to reproduce or otherwise use all or part of the article (including figures and tables), should be referred to JSCRTE by going to our website at http://e-journal.unair.ac.id/index.php/JSCRTE
3. Author Online Use
- Personal Servers. Authors and/or their employers shall have the right to post the accepted version of articles pre-print version of the article, or revised personal version of the final text of the article (to reflect changes made in the peer review and editing process) on their own personal servers or the servers of their institutions or employers without permission from JSCRTE, provided that the posted version includes a prominently displayed JSCRTE copyright notice and, when published, a full citation to the original publication, including a link to the article abstract in the journal homepage. Authors shall not post the final, published versions of their papers;
- Classroom or Internal Training Use. An author is expressly permitted to post any portion of the accepted version of his/her own articles on the author's personal web site or the servers of the author's institution or company in connection with the author's teaching, training, or work responsibilities, provided that the appropriate copyright, credit, and reuse notices appear prominently with the posted material. Examples of permitted uses are lecture materials, course packs, e-reserves, conference presentations, or in-house training courses;
- Electronic Preprints. Before submitting an article to an JSCRTE, authors frequently post their manuscripts to their own web site, their employer's site, or to another server that invites constructive comment from colleagues. Upon submission of an article to JSCRTE, an author is required to transfer copyright in the article to JSCRTE, and the author must update any previously posted version of the article with a prominently displayed JSCRTE copyright notice. Upon publication of an article by the JSCRTE, the author must replace any previously posted electronic versions of the article with either (1) the full citation to the work with a Digital Object Identifier (DOI) or link to the article abstract in JSCRTE homepage, or (2) the accepted version only (not the final, published version), including the JSCRTE copyright notice and full citation, with a link to the final, published article in journal homepage.
4. Articles in Press (AiP) service
JSCRTE may choose to publish an abstract or portions of the paper before we publish it in the journal. Please contact our Production department immediately if you do not want us to make any such prior publication for any reason, including disclosure of a patentable invention.
5. Author/Employer Rights
If you are employed and prepared the article on a subject within the scope of your employment, the copyright in the article belongs to your employer as a work-for-hire. In that case, JSCRTE assumes that when you sign this Form, you are authorized to do so by your employer and that your employer has consented to the transfer of copyright, to the representation and warranty of publication rights, and to all other terms and conditions of this Form. If such authorization and consent has not been given to you, an authorized representative of your employer should sign this Form as the Author.
6. JSCRTE Copyright Ownership
It is the formal policy of JSCRTE to own the copyrights to all copyrightable material in its technical publications and to the individual contributions contained therein, in order to protect the interests of the JSCRTE, its authors and their employers, and, at the same time, to facilitate the appropriate re-use of this material by others. JSCRTE distributes its technical publications throughout the world and does so by various means such as hard copy, microfiche, microfilm, and electronic media. It also abstracts and may translate its publications, and articles contained therein, for inclusion in various compendiums, collective works, databases and similar publications
Every accepted manuscript should be accompanied by "Copyright Transfer Agreement" prior to the article publication.
